Protein binding and hepatic clearance: Studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation

  • William L. Schary
  • Malcolm Rowland
Article

Abstract

The influence of altered drug binding on the hepatic elimination of tolbutamide, a drug of low intrinsic clearance, and on the formation of its metabolite, hydroxytolbutamide, was examined under linear conditions at steady state in the isolated in situsingle-pass perfused rat liver preparation, with perfusate flow fixed at 15 ml/min. The fraction of tulbutamide unbound in the perfusate was varied (from 0.06 to 1.0) by either varying the perfusate concentration of albumin or using albumin of different animal species. The intrinsic clearance of tolbutamide varied fourfold between preparations (0.08–0.36 ml/min/g liver). Within each preparation the data were normalized to observations with a perfusate containing no protein. Both the extraction ratio (and clearance) of tolbutamide and the fraction of tulbutamide appearing as hydroxytolbutamide in effluent perfusate, a measure of hepatic metabolism, were directly proportional to the fraction of tolbutamide unbound in the perfusate.

Key words

tolbutamide hydroxytolbutamide binding clearance extraction ratio perfused rat liver preparation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G. R. Wilkinson and D. G. Shand. Commentary. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).PubMedGoogle Scholar
  2. 2.
    T. N. Tozer. Concepts basic to pharmacokinetics.Pharmacol. Ther. 12:109–132 (1981).PubMedCrossRefGoogle Scholar
  3. 3.
    G. Levy and A. Yacobi. Effect of plasma protein binding on elimination of warfarin.J. Pharm. Sci. 63:805–706 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    R. Gugler, D. W. Shoeman, D. H. Huffman, J. B. Cohlmia, and D. L. Azarnoff. Pharmacokinetics of drug in patients with the nephrotic syndrome.J. Clin. Invest. 55:1182–1186 (1975).PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    D. G. Shand, R. H. Cotham, and G. R. Wilkinson. Perfusion-limited effects of plasma drug binding in hepatic drug extraction.Life Sci. 19:125–130 (1976).PubMedCrossRefGoogle Scholar
  6. 6.
    C-M. Lai and G. Levy. Comparative pharmacokinetics of coumarin anticoagulants. XXX. Relationship between total clearance and serum protein binding of dicoumarol in rats.J. Pharm. Sci. 66:1739–1741 (1977).PubMedCrossRefGoogle Scholar
  7. 7.
    T. W. Guentert and S. Øie. Effect of plasma protein binding on quinidine kinetics in the rabbit.J. Pharmacol. Exp. Ther. 215:165–171 (1980).PubMedGoogle Scholar
  8. 8.
    D. Trenk and E. Jähnchen. Effect of serum protein binding on pharmacokinetics and anticoagulant activity on phenprocoumon in rats.J. Pharmacokin. Biopharm. 8:177–191 (1980).CrossRefGoogle Scholar
  9. 9.
    R. C. Thomas and G. J. Ikeda. The metabolic fate of tolbutamide in man and in the rat.J. Med. Chem. 9:507–510 (1966).PubMedCrossRefGoogle Scholar
  10. 10.
    J. Tagg, D. M. Yasula, M. Tanake, and C. Mitoma. Metabolic studies of tolbutamide in the rat.Biochem. Pharmacol. 16:143–153 (1967).CrossRefGoogle Scholar
  11. 11.
    K. S. Pang and M. Rowland. Hepatic clearance of drugs II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation.J. Pharmacokin. Biopharm. 5:655–680 (1977).CrossRefGoogle Scholar
  12. 12.
    S. B. Matin and M. Rowland. Simultaneous determination of tolbutamide and its metabolities in biological fluids.Anal. Lett. 6:865–876 (1973).CrossRefGoogle Scholar
  13. 13.
    H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall. Protein measurements with the Folin regent.J. Biol. Chem. 193:193–275 (1951).Google Scholar
  14. 14.
    K. S. Pang and M. Rowland. Hepatic clearance of drugs I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.J. Pharmacokin. Biopharm. 5:625–653 (1977).CrossRefGoogle Scholar
  15. 15.
    B. D. Ross.Perfusion Techniques in Biochemistry: A Laboratory Manual. Clarendon Press, Oxford, 1972.Google Scholar
  16. 16.
    J. Judis. Binding of sulfonylureas to serum proteins.J. Pharm. Sci. 61:89–93 (1972).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1983

Authors and Affiliations

  • William L. Schary
    • 1
    • 2
  • Malcolm Rowland
    • 1
  1. 1.Department of PharmacyUniversity of ManchesterManchesterEngland
  2. 2.Pharmaceutical Division, Biochemical DepartmentE. I. DupontWilmington

Personalised recommendations